Zobrazeno 1 - 10
of 26
pro vyhledávání: '"SUIYING HUANG"'
Autor:
BRUCE W. BODE, TIMOTHY S. BAILEY, KRISTIN N. CASTORINO, MARK P. CHRISTIANSEN, SATISH K. GARG, KEVIN B. KAISERMAN, DAVID R. LILJENQUIST, DOROTHY I. SHULMAN, ROBERT H. SLOVER, JOHN SHIN, FEN PENG, SUIYING HUANG, ANDREW S. RHINEHART, ROBERT A. VIGERSKY
Publikováno v:
Diabetes. 71
Objective: A CGM sensor that is disposable and requires no calibration may make glucose management easier for people living with diabetes. The present study reports on the interim analysis of a new disposable zero-calibration sensor in adults and you
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50a1dd55738f61d1c7db26b482f19a10
https://doi.org/10.2337/db22-672-p
https://doi.org/10.2337/db22-672-p
Autor:
Gina Zhang, Barry Horowitz, Ronald L. Brazg, Anuj Bhargava, Satish K. Garg, Yogish C. Kudva, Suiying Huang, Robert Vigersky, Arvind Cavale, George Grunberger, Timothy S. Bailey, Sarnath Chattaraj, Bruce A. Buckingham, John Shin, Vivian Chen, Kevin B Kaiserman, James Thrasher
Publikováno v:
Diabetes. 70
Objective: Most insulin infusion sets (ISs) are labeled for 2- or 3-days use. The Medtronic EWIS is designed to increase wear time up to 7 days. This study reports on EWIS survival and performance during the pivotal trial (ClinicalTrials.gov: NCT0411
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d326dd40f23fa21e724e152827fad1c
https://doi.org/10.2337/db21-100-lb
https://doi.org/10.2337/db21-100-lb
Autor:
Margaret Liu, Suiying Huang, John H. Shin, Xiaoxiao Chen, Andrew S. Rhinehart, Robert A. Vigersky, Toni L. Cordero
Publikováno v:
Diabetes. 70
Background: The Medtronic MiniMed™ AHCL system that autocorrects to 120mg/dL every five minutes and has an automated basal target of 100mg/dL or 120mg/dL has demonstrated improved A1C and time in range1,2 or improved time in closed-loop control,3 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0a8260e528b0c7ed85b79e78050f232
https://doi.org/10.2337/db21-706-p
https://doi.org/10.2337/db21-706-p
Autor:
Vivian Chen, Kevin B Kaiserman, James Thrasher, Anuj Bhargava, Suiying Huang, Barry Horowitz, Bruce A. Buckingham, John Shin, George Grunberger, Gina Zhang, Satish K. Garg, Ronald L. Brazg, Timothy S. Bailey, Arvind Cavale, Robert Vigersky, Sarnath Chattaraj, Yogish C. Kudva
Publikováno v:
Diabetes. 70
Objective: Most insulin infusion sets (ISs) are labeled for 2- or 3-days use. The Medtronic EWIS is designed to increase wear time up to 7 days, and demonstrated a 74.8% survival rate (77.8%, excluding inadvertent early removal) in the pivotal trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1782e8527536b4b5d263d12dc549e2d6
https://doi.org/10.2337/db21-101-lb
https://doi.org/10.2337/db21-101-lb
Autor:
Bruce A. Buckingham, Orit Pinhas-Hamiel, David R Liljenquist, Bruce W. Bode, Kevin B Kaiserman, Francine R. Kaufman, Timothy S. Bailey, Scott W. Lee, Michael A Wood, Suiying Huang, Dorothy I. Shulman, John H. Shin, Gregory P. Forlenza
Publikováno v:
Diabetes Technology & Therapeutics
Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N = 105, ages 7–13 years, mean age 10.8 ± 1.8 years) were enrolled at nine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a078f59f438440f2e0880219e013123
https://pubmed.ncbi.nlm.nih.gov/30585770
https://pubmed.ncbi.nlm.nih.gov/30585770
Autor:
Timothy S. Bailey, Bruce W. Bode, David R Liljenquist, Michael A Wood, Dorothy I. Shulman, Gregory P. Forlenza, Bruce A. Buckingham, Orit Pinhas-Hamiel, Scott W. Lee, Francine R. Kaufman, Suiying Huang, Toni L. Cordero, Kevin B Kaiserman, Xiaoxiao Chen, John H. Shin
Publikováno v:
Diabetes technologytherapeutics. 20(11)
The Medtronic predictive low-glucose management (PLGM) algorithm automatically stops insulin delivery when sensor glucose (SG) is predicted to reach or fall below a preset low-glucose value within the next 30 min, and resumes delivery after hypoglyce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07936edba730ae83aeac94f99e828f6f
https://pubmed.ncbi.nlm.nih.gov/30299976
https://pubmed.ncbi.nlm.nih.gov/30299976
Autor:
John H. Shin, Jennifer L. Sherr, Mark P. Christiansen, Timothy S. Bailey, Francine R. Kaufman, Ashley Sullivan, Scott W. Lee, Kevin B Kaiserman, Linda A. DiMeglio, Ronald L. Brazg, Bruce W. Bode, Robert H. Slover, Eva Tsalikian, Suiying Huang, Jeanie B. Tryggestad, Larry A. Fox
Publikováno v:
Diabetes technologytherapeutics. 20(9)
This study evaluated the safety and performance of the Guardian™ continuous glucose monitoring (CGM) system in children and adolescents with type 1 diabetes (T1D).Subjects 2-18 years of age (mean ± standard deviation [SD] 13.1 ± 3.9 years) with T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0099b8a44d78712aba0b75046a284c69
https://pubmed.ncbi.nlm.nih.gov/30063162
https://pubmed.ncbi.nlm.nih.gov/30063162
Autor:
Francine R. Kaufman, Scott W. Lee, Toni L. Cordero, Bruce W. Bode, Timothy S. Bailey, John H. Shin, Gregory P. Forlenza, Dorothy I. Shulman, Michael A Wood, Suiying Huang, Bruce A. Buckingham
Publikováno v:
Diabetes. 67
In-home use of the MiniMed™ 670G system with SmartGuard™ technology for 3 months improved A1C, 24-hour, and overnight (10PM-7AM) glycemia in T1D patients ≥14 years.1 Recently, the system was shown to improve A1C and time in target range (TIR) (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::492f31ed9f01815d0b1d490ecdecaedb
https://doi.org/10.2337/db18-236-or
https://doi.org/10.2337/db18-236-or
Autor:
Toni L. Cordero, Robert A. Vigersky, Suiying Huang, Scott W. Lee, Harmeet Chhabra, John H. Shin, Francine R. Kaufman, Ohad Cohen
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 24(5)
Fasting C-peptide levels are used to differentiate type 1 from type 2 diabetes (T2D), thereby determining eligibility for coverage of continuous subcutaneous insulin infusion (CSII) for patients with T2D.A total of 168 patients (74 female/94 male, ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc5801d5510ad2bce50dc7ba2a08ad9
https://pubmed.ncbi.nlm.nih.gov/29847166
https://pubmed.ncbi.nlm.nih.gov/29847166
Autor:
Bruce W. Bode, Mark P. Christiansen, Robert H. Slover, Ashley Sullivan, Suiying Huang, Ronald L. Brazg, Francine R. Kaufman, Scott W. Lee, John H. Shin, Timothy S. Bailey, Satish K. Garg
Publikováno v:
Diabetes technologytherapeutics. 19(8)
This study evaluated the accuracy and performance of a fourth-generation subcutaneous glucose sensor (GuardianEighty-eight subjects (14-75 years of age, mean ± standard deviation [SD] of 42.0 ± 19.1 years) with type 1 or type 2 diabetes participate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab962a052b91ea68df807aa7509e5942
https://pubmed.ncbi.nlm.nih.gov/28767273
https://pubmed.ncbi.nlm.nih.gov/28767273